You have 9 free searches left this month | for more free features.

Tumour cell mobilization

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

BRCA or HRR+ Mutated Ovarian Cancer Patients Trial in Worldwide (Olaparib)

Completed
  • BRCA or HRR+ Mutated Ovarian Cancer Patients
  • Plovdiv, Bulgaria
  • +58 more
Dec 21, 2021

Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (VAC?6 vaccine - ?nce at a dose of 106 PFU, VAC?6 vaccine - once at a dose of

Completed
  • Smallpox
  • +3 more
  • VAC∆6 vaccine - оnce at a dose of 10⁶ PFU
  • +3 more
  • Novosibirsk, Koltsovo, Novosibirsk Region, Russian Federation
    Federal State Budgetary Healthcare Institution - Medical and San
Feb 28, 2023

Multiple Myeloma Trial in Houston (Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A))

Not yet recruiting
  • Multiple Myeloma
  • Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A)
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jan 13, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (Fludarabine, Cyclophosphamide, JCAR017)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Santa Monica, California
  • +36 more
Jan 25, 2023

NSCLC Trial in Shanghai (AK112)

Recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
May 23, 2021

Hepatocellular Carcinoma Trial in Shanghai (Chiauranib)

Completed
  • Hepatocellular Carcinoma
  • Shanghai, Shanghai, China
    Zhongshan Hospital of Fudan University
Jun 15, 2021

Refractory Malignant Solid Tumor Trial in Shanghai (anti-MESO CAR T cells)

Recruiting
  • Refractory Malignant Solid Neoplasm
  • anti-MESO CAR T cells
  • Shanghai, China
    Department of Oncology, Ruijin Hospital
Sep 16, 2021

Relapsed or Refractory DLBCL Trial in United States (Selinexor, Rituximab, Bendamustine)

Suspended
  • Relapsed or Refractory Diffuse Large B-Cell Lymphoma
  • Tucson, Arizona
  • +17 more
Jan 24, 2023

Fallopian Tube Carcinosarcoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial in Buffalo

Not yet recruiting
  • Fallopian Tube Carcinosarcoma
  • +10 more
  • Bevacizumab
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 29, 2022

Pediatric Obesity, COVID-19 Trial in Al Kharj (High-intensity aerobic training with high protein diet, Control group)

Completed
  • Pediatric Obesity
  • COVID-19
  • High-intensity aerobic training with high protein diet
  • Control group
  • Al Kharj, Riyadh, Saudi Arabia
    Gopal Nambi
Apr 20, 2022

Heart Failure, Systolic, Pulmonary Disease Trial in Berlin (MyoSuitFeasibility)

Completed
  • Heart Failure, Systolic
  • Pulmonary Disease
  • MyoSuitFeasibility
  • Berlin, Germany
  • +1 more
Nov 16, 2021

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in San Francisco (drug, biological, procedure)

Recruiting
  • Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • San Francisco, California
    University of California, San Francisco
Mar 29, 2022

Semen Quality Trial in Barcelona (Parabolic flight)

Completed
  • Semen Quality
  • Parabolic flight
  • Barcelona, Spain
    Women's Health Dexeus Departament d'Obstetrícia, Ginecologia i R
Mar 30, 2022

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Terminated
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 28, 2022

Non Small Cell Lung Cancer Trial in Wuhan (Carrelizumab, Pemetrexed (Nonsquamous NSCLC) or Nab-paclitaxel(Squamous NSCLC),

Recruiting
  • Non Small Cell Lung Cancer
  • Wuhan, China
    Wuhan Union Hospital
Aug 27, 2021

Traumatic Brain Injuries Trial in Le Kremlin-Bicêtre (Proprioceptive stimulations, Sham stimulations)

Recruiting
  • Traumatic Brain Injuries
  • Proprioceptive stimulations
  • Sham stimulations
  • Le Kremlin-Bicêtre, France
    Bicêtre Hospital
Oct 15, 2021

NSCLC Stage IV Trial in Xiamen (Envafolimab)

Active, not recruiting
  • Non-small Cell Lung Cancer Stage IV
  • Xiamen, Fujian, China
    First affiliated Hospital of Xiamen University
Sep 14, 2021

Sickle Cell Disease, Diffuse Myocardial Fibrosis Trial in Cincinnati (Losartan)

Recruiting
  • Sickle Cell Disease
  • Diffuse Myocardial Fibrosis
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Dec 7, 2021

Colon Cancer Stage I Trial in Taoyuan (Magicell-NK contains NK cells suspended in 100 mL normal saline)

Recruiting
  • Colon Cancer Stage I
  • Magicell-NK contains NK cells suspended in 100 mL normal saline
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital, Linkou
Sep 28, 2022

Cervical Dysplasia, Cervical Cancer Trial in New York (NavDx(R))

Recruiting
  • Cervical Dysplasia
  • Cervical Cancer
  • NavDx(R)
  • New York, New York
    Lenox Hill Hospital
Oct 31, 2022

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Carboplatin)

Recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
  • Kuala Lumpur, Malaysia
    University Malaya Medical Centre
Nov 1, 2022

Recurrent Neuroblastoma Trial in Germany (metronomic therapy)

Recruiting
  • Recurrent Neuroblastoma
  • metronomic therapy
  • Bonn, Germany
  • +7 more
Nov 3, 2022

Pulmonary Arterial Hypertension, Idiopathic Pulmonary Arterial Hypertension, Heritable Pulmonary Arterial Hypertension Trial in

Completed
  • Pulmonary Arterial Hypertension
  • +3 more
  • Smartphone Text Messaging
  • Fitbit Charge HR
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jun 23, 2021

Hematopoietic Stem Cell Transplantation, Art Therapy, Physical Therapy Trial (Art and Physical Therapy, Physical Therapy)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • +2 more
  • Art and Physical Therapy
  • Physical Therapy
  • (no location specified)
Aug 11, 2022

Advanced Cancer Trial in Worldwide (Nivolumab, Dasatinib, Relatlimab)

Terminated
  • Advanced Cancer
  • Nivolumab
  • +4 more
  • Duarte, California
  • +49 more
Feb 23, 2021